


























	 4‐Amino‐2‐(benzylthio)‐6‐(4‐methoxyphenyl)pyrimidine‐5‐carbonitrile	 (1)	was	 prepared	 bytreatment	 of	 s‐benzylthiuronium	 chloride	 with	 2‐(4‐methoxybenzylidene)malononitrile	 in
ethanolic	 sodium	 hydroxide	 with	 hydrazine	 hydrate	 to	 afford	 the	 hydrazino	 derivative	 2,
which	 was	 allowed	 to	 react	 with	 different	 electrophilic	 reagents	 to	 give	 the	 pyrimidine
derivatives	 3‐12.	 The	 proclivity	 of	 (E)‐2‐cyano‐3‐(4‐nitrophenyl)acrylamide	 (13)	 towards
carbon	and	nitrogen	nucleophiles	was	also	investigated.	IR,	1H	NMR	and	mass	spectra	for	all
the	synthesized	compounds	were	discussed.	All	derived	compounds	were	investigated	for	anti











The	 recent	wide	 applications	 of	 pyrimidine	 derivatives	 as	
anti‐tumor	[1],	anti‐HIV‐1	[2],	analgesic	[3],	anti‐depressive	[4],	
anti‐convulsant	 [5],	 anti‐microbial	 [6],	 herbicides	 [7,8],	 anti‐
inflammatory	 and	 antioxidant	 [3,9],	 beside	 their	 uses	 as	 a	
precursors	 in	 the	 synthesis	 of	 fused	 ring	 compounds	 like,	
triazolopyrimidines	as	antibacterial	agents	[10],	fungicidal	[11],	
and	 anti‐tumor	 agents	 [12],	 imidazopyrimidines	 as	
antimycobacterial	 [13]	and	pyridopyrimidines	as	antibacterial	
agents	[14]	make	them	worthy	to	be	synthesized	and	evaluated	
as	 drugs.	 We	 report	 here	 synthesis	 of	 pyrimidine	 and	 fused	
pyrimidines	 by	 developed,	 simple,	 convenient	 and	 efficient	







Melting	points	 are	 uncorrected	 and	were	measured	 by	 an	
electric	 melting	 point	 apparatus	 (G‐K).	 The	 IR	 spectra	 were	
recorded	 on	 a	 Pye‐Unicam	 SP1200	 spectrophotometer	 using	
KBr	Wafer	technique.	The	1H	NMR	spectra	were	determined	on	
a	Varian	GEMINI	300	MHz	NMR	spectrophotometer	using	CDCl3	
or	 DMSO‐d6	 as	 solvent	 and	 TMS	 as	 an	 internal	 standard.	 All	
chemical	shifts	are	in	ppm	downfield	from	TMS.	The	elemental	
analysis	 was	 carried	 out	 in	 faculty	 of	 Science,	 Ain	 Shams	
University.	MS	were	 recorded	on	 Shimadzu	GC‐MS	QP1000EX	










To	a	 solution	of	 s‐benzylthiuronium	chloride	 (2.02	g,	 0.01	
mol)	 in	 water	 (10	 mL),	 sodium	 hydroxide	 (1	 N,	 10	mL)	 was	
added	 dropwise	 with	 shaking,	 the	 pale	 green	 precipitate	 so	
formed,	 was	 dissolved	 in	 warmed	 ethanol	 (10	 mL),	 then	 a	
solution	 of	 2‐(4‐methoxybenzylidene)malononitrile	 (1.84	 g,	
0.01	mol)	in	ethanol	(20	mL)	was	added	and	the	whole	mixture	
was	heated	under	reflux	for	5h.	The	solid	formed	after	cooling	
was	 collected	 by	 filtration	 and	 recrystallized	 from	 toluene	 to	
give	1	as	buff	crystals	(Scheme	1).	Yield:	82%.	M.p.:	171‐173	°C.	




OCH3).	MS	 (EI,	m/z):	 348	 (M+).	Anal.	 Calcd.	 for	C19H16N4OS:	 C,	






A	mixture	 of	 1	 (3.48	 g,	 0.01	mol)	 and	 hydrazine	 hydrate	
80%	(0.015	mol)	 in	ethanol	 (50	mL)	was	heated	under	 reflux	
for	3h.	The	colourless	solid	separated	on	hot	was	collected	by	
filtration	 and	 then	 recrystallized	 from	 dioxane	 to	 give	 2	 as	
colourless	crystals	(Scheme	2).	Yield	35%.	M.p.:	300‐302	°C.	FT‐
IR	 (KBr,	 cm‐1):	 3454,	 3302	 υ(NH2,	 NH),	 2194	 υ(C≡N),	 1634	













A	mixture	 of	 compound	2	 (1.0	 g,	 3.9	mmol)	 and	pentane‐
2,4‐dione	 (0.4	 ml,	 3.9	mmol)	 in	 ethanol	 (25	mL)	 was	 heated	
under	reflux	for	6h.	The	solid	deposited	while	hot	was	collected	




(d,	 J=8.8	 Hz,	 2H,	 Ar‐H),	 6.1	 (s,	 1H,	 =C4‐H),	 4.2	 (br.s,	 2H,	 NH2,	
exchangeable	with	D2O),	3.86	(s,	3H,	OCH3),	3.3	(s,	3H,	C3‐CH3),	







A	solution	of	2	 (1.0	g,	3.9	mmol)	 in	 freshly	distilled	acetic	




184	 °C.	 FT‐IR	 (KBr,	 cm‐1):	 3368	 υ(NH),	 2216	 υ(C≡N),	 1716	
υ(C=O).	 1H	 NMR	 (300	 MHz,	 CDCl3):	 8.17	 (s,	 1H,	 NH,	
exchangeable	with	 D2O),	 8.03	 (d,	 J=8.8	 Hz,	 2H,	 Ar‐H),	 7.27	 (s,	










3h.	 After	 cooling	 the	 reaction	 mixture	 acidified	 on	 ice	 cold	
acetic	acid.	The	deposited	was	filtered	off,	washed	several	times	
with	 cold	 water	 and	 recrystallized	 from	 toluene	 to	 give	 5	 as	









A	mixture	 of	 2	 (1.0	 g,	 3.9	mmol)	 and	 phthalic	 anhydride	
(0.58	g,	3.9	mmol)	in	glacial	acetic	acid	was	heated	under	reflux	
for	one	hour.	The	white	solid	deposited	while	hot	was	collected	
by	 filtration	and	 then	recrystallized	 from	dioxane	 to	give	6	 as	
colourless	 crystals	 (Scheme	 2).	 Yield	 75%.	 M.p.:	 over	 300	 °C.	
FT‐IR	 (KBr,	 cm‐1):	 3414,	 3374,	 3333,	 3168	 υ(NH2,	 NH),	 2205	







A	mixture	 of	2	 (1.0	 g,	 3.9	mmol)	 and	ethyl	 chloroformate	
(0.4	 mL,	 3.9	 mmol)	 in	 pyridine	 (20	 mL)	 was	 heated	 under	
reflux	 for	 6h.	 The	 reaction	 mixture	 was	 concentrated,	 and	
acidified	with	 cold	 dilute	 acetic	 acid.	 The	 solid	 separated	 out	
was	 filtered	 off,	 washed	 several	 times	 with	 cold	 water	 and	
recrystallized	 from	 ethanol	 to	 give	 7	 as	 colourless	 crystals	
(Scheme	 2).	 Yield	 84%.	 M.p.:	 201‐203	 °C.	 FT‐IR	 (KBr,	 cm‐1):	
3468,	 3345,	 3312,	 3173	 υ(NH2),	 2202	 υ(C≡N),	 1706	 υ(C=O)	
(ester).	 1H	 NMR	 (300	 MHz,	 DMSO‐d6):	 9.2‐9.1	 (d,	 2H,	 2NH,	
exchangeable	with	D2O),	 7.82	 (d,	 J=8.6	Hz,	 2H,	 Ar‐H),	 7.08	 (d,	
J=8.6	Hz,	2H,	Ar‐H),	4.1	 (q,	2H,	COOCH2CH3),4.0	 (br.s,	2H,	NH2,	
exchangeable	 with	 D2O),	 3.8	 (s,	 3H,	 OCH3),	 1.2‐1.05	 (t,	 3H,	







































































































dilute	 acetic	 acid.	 The	 canary	 yellow	 solid	 that	 separated	 out	
was	 filtered	 off,	 washed	 several	 times	 with	 cold	 water	 and	
recrystallized	from	ethanol	 to	give	8	as	canary	yellow	crystals	
(Scheme	 3).	 Yield	 48%.	 M.p.:	 278‐280	 °C.	 FT‐IR	 (KBr,	 cm‐1):	
3292,	3213,	3198	υ(NH2,	NH),	2210	υ(C≡N),	1632	υ(C=N),	1259	
υ(C=S).	MS	(EI,	m/z):	298	(M+).	Anal.	Calcd.	 for	C13H10N6OS:	C,	






A	 mixture	 of	 2	 (1.0	 g,	 3.9	 mmol)	 and	 2‐(3,4‐
dimethoxybenzylidene)	 malononitrile	 (0.83	 g,	 3.9	 mmol)	 in	
ethanol	 (25	 mL)	 and	 drops	 of	 glacial	 acetic	 acid	 was	 heated	
under	 reflux	 for	6h.	After	 evaporation	of	 the	solvent	 in	vacuo,	
the	solid	obtained	was	collected	by	filtration	and	recrystallized	
from	toluene	to	give	9	as	pale	yellow	crystals	(Scheme	4).	Yield	
74%.	M.p.:	217‐220	 °C.	 FT‐IR	 (KBr,	 cm‐1):	 3460,	 3292	υ(NH2),	
2200	υ(C≡N),	1643	υ(C=N).	1H	NMR	(300	MHz,	DMSO‐d6):	8.12	
(s,	1H,	Ar‐H),	 7.86	 (d,	 J=8.4	Hz,	2H,	Ar‐H),	 7.30‐7.10	 (br.s,	2H,	
NH2,	exchangeable	with	D2O),	7.18‐6.98	(m,	4H,	Ar‐H),	3.83	(s,	
6H,	2OCH3),	3.79	(s,	3H,	OCH3).	MS	(EI,	m/z):	403	(M+1).	Anal.	

















(KBr,	 cm‐1):	 3478,	 3294,	 3149	 υ(NH2),	 2201	 υ(C≡N),	 1647	
υ(C=N).	 1H	 NMR	 (300	 MHz,	 DMSO‐d6):	 11.7	 (s,	 1H,	 NH,	
exchangeable	with	 D2O),	 8.29	 (m,	 3H,	 (2H,	 Ar‐H)	 and	 N=CH),	










(0.53	 mL,	 3.9	 mmol)	 in	 pyridine	 (25	 mL)	 was	 heated	 under	
reflux	for	6h.	After	cooling	the	reaction	mixture	was	poured	on	
ice	 cold	 acetic	 acid.	 The	 buff	 solid	 that	 separated	 out	 was	
filtered	 off,	 washed	 several	 times	 with	 cold	 water	 and	
recrystallized	from	benzene	to	give	11	(Scheme	5).	Yield	62%.	
M.p.:	 152‐315	 °C.	 FT‐IR	 (KBr,	 cm‐1):	 3204	 υ(NH2,	 NH),	 2204	
υ(C≡N).	 1H	 NMR	 (300	 MHz,	 DMSO‐d6):	 9.75	 (s,	 1H,	 NH,	
exchangeable	with	D2O),	7.49‐7.30	(m,	5H,	Ar‐H),	6.99‐6.96	(d,	
J=8.4	Hz,	2H,	Ar‐H),	6.56‐6.55	(d,	J=8.7	Hz,	2H,	Ar‐H),	4.9	(br.s,	








mL,	3.9	mmol)	 in	n‐butanol	 (20	mL)	 in	 the	presence	of	 acetic	
acid	 (5	mL),	was	heated	under	 reflux	 for	10h.	After	 cooling,	 a	
colourless	 solid	 was	 separated	 out,	 filtered	 off,	 dryed	 and	
recrystallized	 from	 ethanol/dioxane	 mixture	 to	 give	 12	 as	
colourless	crystals	(Scheme	5).	Yield	83%.	M.p.:	268‐270	°C.	FT‐
IR	 (KBr,	 cm‐1):	 3448,	 3361,	 3299	 υ(NH2,	 NH),	 2204	 υ(C≡N),	











ethanol	 (50	 mL)	 in	 the	 presence	 of	 piperidine	 (1.0	 mL)	 was	
heated	with	stirring	for	2h.	The	solid	separated	while	hot	was	







pyrimidin‐4(5H)‐one	 (14):	 Yellow	 crystals.	 Yield	 13%.	 M.p.:	
236‐238	 °C.	 FT‐IR	 (KBr,	 cm‐1):	 3443,	 3410,	 3155	 υ(NH2,	 NH),	




dihydropyrido[2,3‐d]	 pyramidine‐6‐carbonitrile	 (15):	 Buff	
crystals.	 Yield	 56.6%.	 M.p.:	 over	 300	 °C.	 FT‐IR	 (KBr,	 cm‐1):	
3431,	3325	υ(NH2),	2225	υ(C≡N),	1639	υ(C=N).	MS	(EI,	m/z):	




















A	 mixture	 of	 13	 (2.17	 g,	 0.01	 mol)	 with	 2‐(4‐oxo‐4,5‐
dihydrothiazol‐2‐yl)acetonitrile	 (1.4	 g,	 0.01	 mol)	 in	 absolute	
ethanol	 (50	 mL)	 in	 the	 presence	 of	 piperidine	 (1.0	 mL)	 was	
heated	 with	 stirring	 under	 reflux	 for	 8h.	 After	 cooling	 the	
reaction	mixture	 was	 poured	 on	 ice	 and	 acidified	with	 dilute	
acetic	acid.	The	separated	solid	was	filtered	off,	washed	several	
times	with	 cold	water	 and	 recrystallized	 from	ethanol	 to	 give	
17	 as	 red	 crystals	 (Scheme	7).	Yield	62.8%.	M.p.:	 194‐196	 °C.	
FT‐IR	 (KBr,	 cm‐1):	 2208	 υ(C≡N),	 1675	 υ(C=O).	 MS	 (EI,	 m/z):	








A	 mixture	 of	 13	 (2.17	 g,	 0.01	 mol)	 with	 2‐
cyanoacetohydrazide	(0.99	g,	0.01	mol)	in	absolute	ethanol	(50	
mL)	 in	 the	 presence	 of	 piperidine	 (1.0	 mL)	 was	 heated	 with	
stirring	 under	 reflux	 for	 3h.	 The	 yellow	 solid	deposited	while	
hot	was	collected	by	 filtration	and	recrystallized	 from	ethanol	





pyridine‐3‐carboxamide	 (18):	 Yield	 46.5%.	 M.p.:	 201‐203	 °C.	
FT‐IR	(KBr,	cm‐1):	3494,	3403,	3358,	3289,	3186	υ(NH2),	2207	
υ(C≡N),	 1698,	 1656	 υ(C=O).	 MS	 (EI,	 m/z):	 314	 (M+).	 Anal.	
Calcd.	 for	 C13H10N6O4:	 C,	 49.69;	 H,	 3.21;	 N,	 26.74.	 Found:	 C,	
49.62;	H,	3.18;	N,	26.72%.	
(3E,5Z)‐3‐amino‐6‐cyano‐5‐(4‐nitrophenyl)‐7‐oxo‐2,7‐
dihydro‐1H‐1,2‐diazepine‐4‐carboxamide	 (19):	 Yield	 15.7%.	













water	 bath	 for	 16h.	 After	 cooling	 the	 reaction	 mixture	 was	
poured	 on	 ice	 and	 acidified	 with	 dilute	 acetic	 acid.	 The	
precipitated	 solid	was	 filtered	 off,	 washed	 several	 times	with	
cold	water	and	recrystallized	from	methanol	to	give	20	as	light	
brown	crystals	(Scheme	7).	Yield	32%.	M.p.:	over	300	°C.	FT‐IR	
(KBr,	 cm‐1):	 3421	 υ(NH2),	 2213	 υ(C≡N),	 1690	 υ(C=O),	 1621	
υ(C=N),	 1342	 υ(C=S).	MS	 (EI,	m/z):	 322	 (M‐H2S).	 Anal.	 Calcd.	













Samples	 were	 diluted	 with	 Dulbecco's	 Modified	 Eagle's	
Medium	(DMEM)	 to	desired	concentrations.	Stock	solutions	of	
the	 test	 compounds	were	 prepared	 in	 10	%	DMSO	 in	 ddH2O.	
The	cytotoxic	activity	of	the	extracts	was	tested	in	Madin	Darby	
Canine	 kidney	 (MDCK)	 cells	 by	 using	 the	 3‐(4,5‐
dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium	 bromide	 (MTT)	
method	 [15]	 with	 minor	 modification.	 Briefly,	 the	 cells	 were	




was	 discarded	 and	 cell	monolayers	were	washed	with	 sterile	
phosphate	buffer	saline(PBS)	3	times	and	MTT	solution	(20	µL	
of	 5	 mg/mL	 stock	 solution)	 was	 added	 to	 each	 well	 and	
incubated	at	37	°C	for	4	hrs	followed	by	medium	aspiration.	In	
each	well,	 the	 formed	 formazan	 crystals	 were	 dissolved	with	
200	 µL	 of	 acidified	 isopropanol	 (0.04	 M	 HCl	 in	 absolute	
isopropanol).	 Absorbance	 of	 formazan	 solutions	 were	
measured	 at	 λmax	 540	 nm	 with	 620	 nm	 as	 a	 reference	
wavelength	using	a	multi‐well	plate	reader.	The	percentage	of	












The	 antiviral	 activity	 of	 the	 compounds	 was	 determined	
using	 cytopathogenicity	 (CPE)	 assay	 against	 avian	 influenza	
virus	 (H5N1).	 Stock	 solutions	 of	 the	 test	 compounds	 were	
prepared	in	DMSO	at	a	concentration	of	10	mg/mL.	Cells	grown	
to	 confluency	 in	 96‐well	 plates,	were	 infected	with	 100	 µL	 of	
stock	virus.	After	an	adsorption	period	of	2	hrs	at	37	 oC,	virus	
was	 removed	 and	 serial	 dilutions	 of	 the	 compounds	 were	
added.	 Maintenance	 DMEM	 with	 2%	 FBS	 was	 added	 (100	
µL/well).The	 cultures	 were	 further	 incubated	 at	 37	 oC	 for	 3	
days,	 until	 complete	 CPE	 was	 observed	 in	 the	 infected	 and	
untreated	virus	control.	The	determination	of	the	anti‐influenza	
virus	 activity	 of	 the	 compounds	 was	 based	 on	 virus‐induced	










of	 heterocyclic	 systems	 [17‐26]	 encouraged	 us	 to	 synthesize	
pyrimidine	 derivatives	 from	 relatively	 simple	 starting	
materials.	 The	 title	 compound	1	 was	 prepared	 by	 reaction	 of				
2‐(4‐methoxybenzylidene)malononitrile	 with	 s‐benzylthiuro‐
nium	 chloride	 in	 refluxing	 ethanolic	 sodium	 hydroxide	
according	the	simple	mechanism	in	(Scheme	1).	
Hydrazinolysis	 of	 1	 afforded	 the	 sulfur	 free	 compound	
which	 identified	 as	 4‐amino‐2‐hydrazinyl‐6‐(4‐methoxy	
phenyl)pyrimidine‐5‐carbonitrile	(2)	[6]	(Scheme	2).	
Recently,	 it	 has	 been	 reported	 [27]	 that	 the	 hydrazino	
pyrimidines	can	be	considered	as	key	starting	materials	for	the	
synthesis	 of	 diverse	 nitrogen	 bridgehead	 compounds.	 This	
prompted	us	to	reinvestigate	the	proclivity	of	compound	2	with	
electrophilic	 reagents	 such	 as,	 pentane‐2,4‐dione,	 acetic	
anhydride,	 furoyl	 chloride,	 phthalic	 anhydride,	 ethyl	 chloro‐
formate,	 carbon	 disulphide,	 2‐(3,4‐dimethoxybenzylidene)	
malononitrile,	p‐nitrobenzaldehyde,	phenyl	isothiocyanate	and	






























































































Thus,	 treatment	 of	 the	 2‐hydrazino	 derivative	 2	 with	
pentane‐2,4‐dione	 in	 refluxing	 ethanol	 afforded	 4‐amino‐2‐
(3,5‐dimethyl‐1H‐pyrazol‐1‐yl)‐6‐(4‐methoxyphenyl)pyrimi‐
dine‐5‐carbonitrile	(3)	[6].	
Acetylation	 of	 compound	 2	 using	 freshly	 distilled	 acetic	
anhydride	 yielded	 the	 acetylated	 product	 (4).	 The	 mass	





derivative	 (6).	 Furthermore,	 compound	 2	 when	 treated	 with	
ethyl	 chloroformate	 yielded	 ethyl	 N‐pyrimidin‐2‐yl	 carbazate	
derivative	(7)	(Scheme	2).	
The	 structures	 4‐7	 were	 substantiated	 from	 the	 correct	




including	 furans,	 pyrimidines	 and	 quinazolines	 [28]	 reacted	
with	 carbon	 disulphide	 under	 different	 conditions	 to	 afford	
biologically	 interest	 fused	 thiazines	 and	 pyrimidinedithione.	
However,	 compound	2	was	 treated	with	 carbon	disulphide	 in	
ethanolic	 potassium	 hydroxide	 to	 yield	 7‐amino‐5‐(4‐
methoxyphenyl)‐3‐thioxo‐2,3‐dihydro‐[1,2,4]‐triazolo[4,3‐a]	




obtained	 in	 fairly	 good	 yield	 upon	 treatment	 of	 compound	2	





Refluxing	 the	 hydrazino	 derivative	 2	 with	 p‐nitro	
benzaldehyde	 in	 ethanol	 for	 10	 min	 afforded	 a	 crude	 yellow	




In	 the	 context,	 it	 was	 claimed	 that	 the	 reaction	 of	 the	
hydrazino	 derivative	 with	 phenyl	 isothiocyanate	 in	 refluxing	
pyridine	 resulted	 in	 the	 formation	 of	 1,2,4‐triazolo‐	
pyrimidinthione	 or	 thiourea	 derivatives	 [27].	 Herein,	 when	
compound	 2	 was	 refluxed	 with	 the	 same	 reagent	 in	 boiling	





in	 the	 presence	 of	 acetic	 acid	 afforded	 the	 mono	 acetylated	






(13)	 was	 prepared	 and	 allowed	 to	 react	 with	 carbon	 and	
nitrogen	nucleophiles.	Thus,	the	reaction	of	13	with	6‐amino‐2‐
thioxo‐2,3‐dihydropyrimidin‐4(1H)‐one	 in	 boiling	 ethanol	 in	
the	 presence	 of	 piperidine	 yielded	 a	 yellow	 solid	 product	
separated	on	hot	and	identified	as	the	pyrimidine	derivative	14	
(13%).	Acidification	of	 the	alkaline	 filtrate	 left	a	solid	product	

















































































13	 and	 subsequent	 1,6‐exo‐trig	 cyclization	 through	
nucleophilic	 addition	 of	 the	 amino	 group	 to	 the	 carboxamido	
carbonyl	group	(Scheme	6).	
Furthermore,	 treatment	 of	 13	 with	 2‐(4‐oxo‐4,5‐







N‐Amino‐2‐pyridones	 have	 proved	 to	 be	 useful	 synthetic	
intermediates	 [32‐35].	 However,	 there	 are	 few	 synthetic	
procedures	for	the	preparation	of	N‐amino‐2‐pyridones.	These	
compounds	 are	 usually	 obtained	 [36‐39]	 in	 low	 yields	 by	
reaction	 of	 hydrazine	 with	 2‐pyrones,	 which	 are	 in	 turn	
prepared	 in	 low	 yields	 from	 open	 chain	 compounds	 [35‐44].	
We	 report	 in	 this	 article	 one	 step	 synthesis	 of	 N‐amino‐2‐
pyridone	(18)	from	compound	13	with	2‐cyanoacetohydrazide.	
The	reaction	easily	performed	in	ethanol	at	room	temperature	
in	 the	 presence	 of	 piperidine	 by	 stirring	 for	 two	 hours.	 The	
separated	 solid	 was	 identified	 using	 analytical	 and	 spectral	
data	 as	 1,2‐diamino‐5‐cyano‐4‐(4‐nitrophenyl)‐6‐oxo‐1,6‐
dihydropyridine‐3‐carboxamide	 (18).	 Acidification	 of	 the	
mother	 liquor	 left	 another	 yellow	 solid	 which	 have	 the	 same	
molecular	formula	of	compound	18.	This	product	was	expected	
to	have	the	diazepinone	structure	19	(Scheme	7).	
The	 reaction	 may	 be	 assumed	 to	 proceed	 via	 Michael	
addition	 of	 2‐cyanoacetohydrazide	 to	 13	 and	 the	 resulting	
adduct	 undergoes	 in	 situ	 cyclization	 by	 nucleophilic	 attack	 at	
the	 cyano	 group	 to	 give	 the	 six	 membered	 ring	 which	 on	
aromatization	gives	rise	to	the	N‐amino‐2‐pyridone	(18)	(route	
a).	 A	 cyclization	 to	 seven‐membered	 diazepine	 ring	 must	 be	
favored	 by	 the	 higher	 nucleophilic	 character	 of	 the	 amino	
group	with	respect	to	the	CONH	group,	but	the	poor	yield	of	19,	
probably	 due	 to	 the	 lack	 of	 aromatic	 character	 of	 the	
diazepinone	ring	19	(Scheme	8).	
Beside	the	analytical	and	spectral	data	the	structure	18	was	
got	 a	 further	 chemical	 support	 by	 the	 reaction	 with	 carbon	
disulphide.	 However,	 when	 compound	 18	 was	 treated	 with	
carbon	 disulphide	 in	 ethanolic	 potassium	 hydroxide	 at	





The	 results	 were	 expressed	 as	 the	 50%	 effective	
concentration	(EC50).	The	50%	effective	antiviral	concentration	
(EC50)	was	defined	as	the	compound	concentration	required	for	
protecting	 50%	 of	 the	 virus‐infected	 cells	 against	 viral	
cytopathogenicity.	 The	 therapeutic	 index	 was	 calculated	 by	
dividing	LD50	on	EC50	(Figure	1).	
Therapeutic	 index	 was	 calculated	 to	 all	 examined	
compounds	 and	 compared	 with	 Zanamivir	 as	 control	 anti‐
influenza	drug	as	shown	in	Table	1.	
	






















Figure	 1.	 The	 50%	 effective	 concentration	 (EC50)	 and	 the	 concentration,	






The	 potentially	 synthetic	 value	 of	 the	 newly	 reported	
compounds,	 as	 excellent	 starting	 materials,	 stimulated	 our	
interest	to	utilize	them	for	the	synthesis	of	the	title	compounds,	
in	 anticipation	 that	 new	 compounds	 would	 exhibit	
pharmacological	activity.	All	 the	synthesized	compounds	were	
examined	 and	 compared	 with	 Zanamivir	 as	 control	 anti‐
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